Tianjin Ringpu Bio-TechnologyLtd Management
Management criteria checks 3/4
Tianjin Ringpu Bio-TechnologyLtd's CEO is Lei Xu, appointed in Mar 2023, has a tenure of 1.75 years. directly owns 0.047% of the company’s shares, worth CN¥4.17M. The average tenure of the management team and the board of directors is 2.3 years and 2.3 years respectively.
Key information
Lei Xu
Chief executive officer
CN¥1.2m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.8yrs |
| CEO ownership | 0.05% |
| Management average tenure | 2.3yrs |
| Board average tenure | 2.3yrs |
Recent management updates
Recent updates
There's No Escaping Tianjin Ringpu Bio-Technology Co.,Ltd.'s (SZSE:300119) Muted Earnings Despite A 29% Share Price Rise
Nov 26
Is There An Opportunity With Tianjin Ringpu Bio-Technology Co.,Ltd.'s (SZSE:300119) 42% Undervaluation?
Nov 25Solid Earnings May Not Tell The Whole Story For Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119)
Nov 05These 4 Measures Indicate That Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119) Is Using Debt Reasonably Well
Oct 30The Market Lifts Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) Shares 36% But It Can Do More
Oct 08Tianjin Ringpu Bio-Technology Co.,Ltd. Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Aug 26Improved Earnings Required Before Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) Shares Find Their Feet
Aug 23Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119) Seems To Use Debt Quite Sensibly
Jun 26Impressive Earnings May Not Tell The Whole Story For Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119)
Apr 05Tianjin Ringpu Bio-Technology Co.,Ltd.'s (SZSE:300119) Subdued P/E Might Signal An Opportunity
Mar 28CEO
Lei Xu (51 yo)
1.8yrs
Tenure
CN¥1,169,300
Compensation
Mr. Lei Xu serves as General Manager since March 30, 2023 and Non-Independent Director of Tianjin Ringpu Bio-Technology Co.,Ltd. Since September 13, 2022. He served as Director and Deputy General Manager a...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 1.8yrs | CN¥1.17m | 0.047% CN¥ 4.2m | |
| Financial Manager | 2.7yrs | CN¥459.60k | 0.0032% CN¥ 287.1k | |
| Deputy GM & Director | no data | CN¥1.01m | 0.034% CN¥ 3.0m | |
| Non-Independent Director & Deputy GM | no data | CN¥780.20k | 0.021% CN¥ 1.9m | |
| Board Secretary | 2.3yrs | CN¥644.90k | no data | |
| Deputy General Manager | 2.3yrs | CN¥1.13m | 0.034% CN¥ 3.0m | |
| Chief Inspector of Technology Centre | no data | no data | 2.42% CN¥ 213.9m |
2.3yrs
Average Tenure
49yo
Average Age
Experienced Management: 300119's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 2.3yrs | CN¥1.17m | 0.047% CN¥ 4.2m | |
| Deputy GM & Director | 6yrs | CN¥1.01m | 0.034% CN¥ 3.0m | |
| Non-Independent Director & Deputy GM | 2.3yrs | CN¥780.20k | 0.021% CN¥ 1.9m | |
| Chairman | 16.6yrs | CN¥1.58m | 36.32% CN¥ 3.2b | |
| Director | 6yrs | CN¥402.50k | 0.0026% CN¥ 229.7k | |
| Non-Independent Director | 2.3yrs | CN¥100.00k | 0.0033% CN¥ 293.3k | |
| Independent Director | 2.3yrs | CN¥100.00k | no data | |
| Independent Director | 2.3yrs | no data | no data | |
| Independent Director | 2.3yrs | CN¥100.00k | no data | |
| Chairman of the Supervisory Board | 2.3yrs | no data | 1.12% CN¥ 99.3m | |
| Supervisor | 1.8yrs | no data | no data |
2.3yrs
Average Tenure
51yo
Average Age
Experienced Board: 300119's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 10:22 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Tianjin Ringpu Bio-Technology Co.,Ltd. is covered by 19 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jia Chen | Changjiang Securities Co. LTD. |
| Xu Qing Liu | Chasing Securities |
| Junhao Fan | China International Capital Corporation Limited |